Anticardiolipin Antibodies as Additional Risk Factor in Proliferative Diabetic Retinopathy

被引：0

作者：

Aamir, Hooria ^{[1
]}

Huda, Amtul ^{[2
]}

Khans, Memon Muhammad ^{[3
]}

Aitazaz, Fauzia ^{[4
]}

Ali, Zulfiqar ^{[5
]}

Akbar, Afsheen ^{[6
]}

Shaukat, Minahal ^{[7
]}

机构：

[1] Punjab Med Coll Faisalabad, Dept Physiol, Faisalabad, Pakistan

[2] Abbottabad Int Med & Dent Coll, Dept Physiol, Abbottabad, Pakistan

[3] Hera Gen Hosp, Dept Ophthalmol, Holy Makkah, Saudi Arabia

[4] Azad Jammu Kashmir Med Coll Muzaffarabad AK, Dept Physiol, Muzaffarabad, Pakistan

[5] Avicenna Med Coll, Dept Pathol, Lahore, Pakistan

[6] Avicenna Med Coll, Dept Physiol, Lahore, Pakistan

[7] Univ Med & Dent Coll, Faisalabad, Pakistan

来源：

PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES | 2020年 / 14卷 / 01期

关键词：

Proliferative diabetic retinopathy; Anticardiolipin antibodies; Antiphospholipid antibodies (APLA); Intravitreal vascular endothelial growth factor; high-risk criterion; ANTIPHOSPHOLIPID SYNDROME;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Aim: In patients of proliferative diabetic retinopathy (PDR) the prevalence of anticardiolipin antibodies (aCL) account as high-risk criterion (HRC).(1) Methods: Both groups of Diabetic and non diabetics patients contain PDR by way of HRC and were compared for anticardiolipin antibodies presence. Results: Amongst the 40 patients, 9(22.5%) of the diabetic subjects having PDR with HRC had anticardiolipin antibodies positive results. There were no significant relationships of (aCL) antibodies with type of diabetes or gender. By using Pearson's association test, no significant relations of (aCL) antibodies with diabetes or age of subject would be establish. Statistically significant difference was found in all subjects with positive results of (aCL) had PDR along with HRC. Conclusion: Presence of anticardiolipin antibodies (aCL) may signify as a supplementary risk factor for PDR.

引用

页码：179 / 181

页数：3

共 12 条

[1] Anti-cardiolipin antibodies and circulating immune complexes in type 1 diabetes mellitus: increased prevalence and relation to vascular complications
Ahmed, E
Nityanand, S
Mustafa, A
Brismar, K
Lefvert, AK
[J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1999, 115 (02) : 255 - 259
[2] Simultaneous bilateral central retinal vein occlusion associated with anticardiolipin antibodies in leukemia
Al-Abdulla, NA
Thompson, JT
LaBorwit, SE
[J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2001, 132 (02) : 266 - 268
[3] Bloodworth J.M.B., 1968, AM J MED, V90, p67S
[4] Bloodworth J.M.B., ENDOCRINE PATHOLOGY, P389
[5] The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis
Bordron, A
Dueymes, M
Levy, Y
Jamin, C
Leroy, JP
Piette, JC
Shoenfeld, Y
Youinou, PY
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (10) : 2029 - 2035
[6] IMMUNOHISTOPATHOLOGIC STUDY OF LOCALIZED PLASMA PROTEINS AND FIXATION OF GUINEA PIG COMPLEMENT IN RENAL LESIONS OF DIABETIC GLOMERULOSCLEROSIS
BURKHOLD.PM
[J]. DIABETES, 1965, 14 (12) : 755 - &
[7] CABIEDES J, 1995, J RHEUMATOL, V22, P1899
[8] Genetic risk factors of thrombosis in the antiphospholipid syndrome
Castro-Marrero, Jesus
Balada, Eva
Vilardell-Tarres, Miquel
Ordi-Ros, Josep
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2009, 147 (03) : 289 - 296
[9] Presence of antiphospholipid antibody is a risk factor in thrombotic events in patients with antiphospholipid syndrome or relevant diseases
Habe, Koji
Wada, Hideo
Matsumoto, Takeshi
Ohishi, Kohshi
Ikejiri, Makoto
Matsubara, Kimiko
Morioka, Tatsuhiko
Kamimoto, Yuki
Ikeda, Tomoaki
Katayama, Naoyuki
Nobori, Tsutomu
Mizutani, Hitoshi
[J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (03) : 345 - 350
[10] The clinical performance of a chemiluminescent immunoassay in detecting anti-cardiolipin and anti-β2 glycoprotein I antibodies. A comparison with a homemade ELISA method
Meneghel, Lauro
Ruffatti, Amelia
Gavasso, Sabrina
Tonello, Marta
Mattia, Elena
Spiezia, Luca
Campello, Elena
Hoxha, Ariela
Fedrigo, Marny
Punzi, Leonardo
Simioni, Paolo
[J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2015, 53 (07) : 1083 - 1089

← 1 2 →